IP Due Diligence

"[G]reat to bring into play when you need core technical dexterity." - IAM 1000

Our IP lawyers also conduct IP due diligence in corporate transactions and in other contested matters, such as complex bankruptcy proceedings, and anti-counterfeiting and infringement actions. They have particularly extensive experience dealing with the complexities of handling IP rights in bankruptcy proceedings where there has been an acute demand for skilled IP lawyers capable of advising clients in the disposition of highly valuable IP rights in bankruptcy. Of particular note are the intense proceedings involving the bankruptcies of Chrysler and of General Motors where our IP Group teamed up with Cadwalader's other practices to represent the United States Treasury in achieving successful conclusions with unheard-of speed.

  • Towers Watson in an asset sale to Jardine Lloyd Thompson, including negotiation of the IP portions of the transaction.
  • Elan Corp. in connection with the sale of its Tysabri® business to Biogen Idec for $3.25 billion in cash and additional future royalties.
  • Elan Corp. in relation to a royalty participation agreement with Theravance for $1.0 billion in RELVAR™ ELLIPTA™/BREO™ ELLIPTA™, ANORO™ and ELLIPTA™, programs.
  • AngioDynamics, Inc. in its acquisition of Navilyst Medical for $373 million.
  • Pfizer in its acquisition of Wyeth for $68 billion.
  • Triarco Industries in the sale of its nutritional and dietary supplement manufacturing business to Innophos Holdings.
  • A major financial institution in connection with the acquisition of hospitality franchising chain worth approximately $1.5 billion.
  • A major financial institution in connection with the financing of landmark hotel for approximately $500 million.
  • Fortune 500 technology companies in the analysis of various intellectual property for acquisitions and licensing.
  • A biopharmaceutical company in the exclusive licensing of its patent portfolio covering medications related to digestive acids.
  • A biopharmaceutical company in the preparation of a collaborative research agreement with a public university.

8 Attorneys

Auth Ph.D., Dorothy R. Partner New York
T. +1 212 504 6018
Cole, Dash Associate New York
T. +1 212 504 6755
Hughes, Christopher A. Senior Counsel New York
T. +1 212 504 6891
Moehringer, John T. Partner New York
T. +1 212 504 6731
Pollaro, Robert M. Special Counsel New York
T. +1 212 504 6484
Powell, Michael B. Associate New York
T. +1 212 504 6246
Tully, Danielle Vincenti Associate New York
T. +1 212 504 6585
Wizenfeld, Howard Special Counsel New York
T. +1 212 504 6050

Contact(s)

Christopher A. Hughes
+1 212 504 6891 
christopher.hughes@cwt.com
v-card

Cadwalader News

ACI Summit on Controlled Substances: Regulation, Litigation and Enforcement

Jodi Avergun is speaking at this ACI event on January 30 in Washington, DC.

Cadwalader Subscription Center